Final amended report on the safety assessment of Ammonium Thioglycolate, Butyl Thioglycolate, Calcium Thioglycolate, Ethanolamine Thioglycolate, Ethyl Thioglycolate, Glyceryl Thioglycolate, Isooctyl Thioglycolate, Isopropyl Thioglycolate, Magnesium Thioglycolate, Methyl Thioglycolate, Potassium Thioglycolate, Sodium Thioglycolate, and Thioglycolic Acid. 2009

Christina L Burnett, and Wilma F Bergfeld, and Donald V Belsito, and Curtis D Klaassen, and James G Marks, and Ronald C Shank, and Thomas J Slaga, and Paul W Snyder, and , and F Alan Andersen
Cosmetic Ingredient Review, 1101 17th Street, NW, Suite 412, Washington, DC 20036, USA. cirinfo@cir-safety.org

This safety assessment includes Ammonium and Glyceryl Thioglycolate and Thioglycolic Acid Butyl, Calcium, Ethanolamine, Ethyl, Isooctyl, Isopropyl, Magnesium, Methyl, Potassium, and Sodium Thioglycolate, as used in cosmetics. Thioglycolates penetrate skin and distribute to the kidneys, lungs, small intestine, and spleen; excretion is primarily in urine. Thioglycolates were slightly toxic in rat acute oral toxicity studies. Thioglycolates are minimal to severe ocular irritants. Thioglycolates can be skin irritants in animal and in vitro tests, and can be sensitizers. A no-observable-adverse-effect level for reproductive and developmental toxicity of 100 mg/kg per day was determined using rats. Thioglycolates were not mutagenic, and there was no evidence of carcinogenicity. Thioglycolates were skin irritants in some clinical tests. Clinically significant adverse reactions to these ingredients used in depilatories are not commonly seen, suggesting current products are formulated to be practically nonirritating under conditions of recommended use. Formulators should take steps necessary to assure that current practices are followed.

UI MeSH Term Description Entries
D003358 Cosmetics Substances intended to be applied to the human body for cleansing, beautifying, promoting attractiveness, or altering the appearance without affecting the body's structure or functions. Included in this definition are skin creams, lotions, perfumes, lipsticks, fingernail polishes, eye and facial makeup preparations, permanent waves, hair colors, toothpastes, and deodorants, as well as any material intended for use as a component of a cosmetic product. (U.S. Food & Drug Administration Center for Food Safety & Applied Nutrition Office of Cosmetics Fact Sheet (web page) Feb 1995) Personal Care Products,Care Product, Personal,Care Products, Personal,Personal Care Product,Product, Personal Care,Products, Personal Care
D006016 Glycolates Derivatives of ACETIC ACID which contain an hydroxy group attached to the methyl carbon. 2-Hydroxyacetates,Glycolate Ethers,Hydroxyacetate Ethers,Hydroxyacetates,Hydroxyacetic Acids,2 Hydroxyacetates,Acids, Hydroxyacetic,Ethers, Glycolate,Ethers, Hydroxyacetate
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014018 Tissue Distribution Accumulation of a drug or chemical substance in various organs (including those not relevant to its pharmacologic or therapeutic action). This distribution depends on the blood flow or perfusion rate of the organ, the ability of the drug to penetrate organ membranes, tissue specificity, protein binding. The distribution is usually expressed as tissue to plasma ratios. Distribution, Tissue,Distributions, Tissue,Tissue Distributions
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D019055 No-Observed-Adverse-Effect Level The highest dosage administered that does not produce toxic effects. NOAEL,No-Observed-Effect Level,Acceptable Daily Intake,Tolerable Daily Intake,Acceptable Daily Intakes,Daily Intake, Acceptable,Daily Intake, Tolerable,Daily Intakes, Acceptable,Daily Intakes, Tolerable,Intake, Acceptable Daily,Intake, Tolerable Daily,Intakes, Acceptable Daily,Intakes, Tolerable Daily,Level, No-Observed-Adverse-Effect,Level, No-Observed-Effect,Levels, No-Observed-Adverse-Effect,Levels, No-Observed-Effect,No Observed Adverse Effect Level,No Observed Effect Level,No-Observed-Adverse-Effect Levels,No-Observed-Effect Levels,Tolerable Daily Intakes

Related Publications

Christina L Burnett, and Wilma F Bergfeld, and Donald V Belsito, and Curtis D Klaassen, and James G Marks, and Ronald C Shank, and Thomas J Slaga, and Paul W Snyder, and , and F Alan Andersen
January 2001, International journal of toxicology,
Christina L Burnett, and Wilma F Bergfeld, and Donald V Belsito, and Curtis D Klaassen, and James G Marks, and Ronald C Shank, and Thomas J Slaga, and Paul W Snyder, and , and F Alan Andersen
January 2002, International journal of toxicology,
Christina L Burnett, and Wilma F Bergfeld, and Donald V Belsito, and Curtis D Klaassen, and James G Marks, and Ronald C Shank, and Thomas J Slaga, and Paul W Snyder, and , and F Alan Andersen
January 2003, International journal of toxicology,
Christina L Burnett, and Wilma F Bergfeld, and Donald V Belsito, and Curtis D Klaassen, and James G Marks, and Ronald C Shank, and Thomas J Slaga, and Paul W Snyder, and , and F Alan Andersen
January 2007, International journal of toxicology,
Christina L Burnett, and Wilma F Bergfeld, and Donald V Belsito, and Curtis D Klaassen, and James G Marks, and Ronald C Shank, and Thomas J Slaga, and Paul W Snyder, and , and F Alan Andersen
January 2009, International journal of toxicology,
Christina L Burnett, and Wilma F Bergfeld, and Donald V Belsito, and Curtis D Klaassen, and James G Marks, and Ronald C Shank, and Thomas J Slaga, and Paul W Snyder, and , and F Alan Andersen
January 2003, International journal of toxicology,
Christina L Burnett, and Wilma F Bergfeld, and Donald V Belsito, and Curtis D Klaassen, and James G Marks, and Ronald C Shank, and Thomas J Slaga, and Paul W Snyder, and , and F Alan Andersen
July 2008, Acta crystallographica. Section C, Crystal structure communications,
Christina L Burnett, and Wilma F Bergfeld, and Donald V Belsito, and Curtis D Klaassen, and James G Marks, and Ronald C Shank, and Thomas J Slaga, and Paul W Snyder, and , and F Alan Andersen
January 2005, International journal of toxicology,
Christina L Burnett, and Wilma F Bergfeld, and Donald V Belsito, and Curtis D Klaassen, and James G Marks, and Ronald C Shank, and Thomas J Slaga, and Paul W Snyder, and , and F Alan Andersen
January 2009, International journal of toxicology,
Copied contents to your clipboard!